$0.00—Stale · unknown old
OTCMARKET • Last print unknown ago
$0.00—Stale · unknown old
Entia Biosciences, Inc. is a biotechnology company focused on developing innovative health solutions through its proprietary technology platform, which leverages bioinformatics and personalized medicine. The company operates primarily in the United States and is positioned to capitalize on the growing demand for personalized health products, particularly in the nutraceuticals sector.
Entia generates revenue primarily through the sale of its proprietary nutraceutical products, which are designed to enhance health and wellness based on individual genetic profiles. The company benefits from strong pricing power due to its unique product offerings and the increasing consumer trend towards personalized health solutions.
Regulatory approvals for new products
Partnerships with health and wellness retailers
Consumer adoption rates of personalized health products
Advancements in bioinformatics technology
Regulatory changes affecting the biotechnology sector
Technological disruption from emerging health technologies
Intense competition from established nutraceutical brands
Potential market entry of larger pharmaceutical companies
High operational losses impacting liquidity
Limited cash reserves for operational sustainability
moderate - The demand for health and wellness products can be somewhat insulated from economic downturns, but discretionary spending on nutraceuticals may decline during recessions.
The company's financing costs may increase with rising interest rates, impacting its ability to fund R&D and operational expansion, which could affect valuation multiples.
minimal - The company has a negative debt/equity ratio, indicating minimal reliance on external financing.
growth - Investors seeking high-growth opportunities in the biotechnology and health sectors may find Entia appealing due to its innovative product offerings.
high - The stock has exhibited extreme volatility, with a recent 500% return over the past year indicating speculative trading.